Should You Buy Zomedica in April?

Zomedica (NYSEMKT: ZOM) has been one of the hottest stocks of 2021, soaring more than 340% this year and dwarfing the S&P 500 and its 10% gains in the process. With such extreme volatility in less than four months, this is a stock that investors should be careful with and take a closer look at before making an investment decision. Below, I'll look at what has been driving the stock's price this year and assess whether Zomedica is just another meme stock benefiting from a rise in internet fame, or if it is an investment that is actually suitable for your portfolio.